ASTX727 and Donor Lymphocyte Infusions After Allogenic Stem Cell Transplantation in Very High Risk MDS or AML Patients
Clinical trial NCT04857645 · COMPLETED
Trial details
- NCT number
- NCT04857645
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-22
- Primary completion
- 2024-04-30
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.